How a retracted UK Covid-19 vaccine study tainted the global hunt for mutation-proof shots
GlobeAlert Desk · curated from South China Morning Post · global
A 2022 study exploring a vaccine design for pan-Sars-CoV-2 immunity was retracted last month after its lead author, then in Britain, admitted to fabricating data and falsifying images in the paper. While the retraction of the study, widely cited up until this year by international scientists, marks a significant blow to vaccine research, virologists said the foundational science targeting broader coronavirus immunity remained robust and independent of the retracted study. Citation records show...
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
What the desk knows about this story
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Single-source so far. Treat details as unconfirmed until more publishers report.
Not flagged as developing.